• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

2.630 +0.010 (+0.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 Next >
News headline image
Evotec Nominates Dieter Weinand as Supervisory Board Chairman
April 07, 2026
Via ACCESS Newswire
News headline image
Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
April 01, 2026
Via ACCESS Newswire
News headline image
Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
April 01, 2026
Via ACCESS Newswire
News headline image
Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
March 23, 2026
Via ACCESS Newswire
News headline image
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
March 19, 2026
Via ACCESS Newswire
News headline image
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
March 04, 2025
Via ACCESS Newswire
News headline image
Evotec Announces Change in Management Board
February 26, 2025
Via ACCESS Newswire
News headline image
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 08, 2026
Via ACCESS Newswire
News headline image
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
January 02, 2026
Via ACCESS Newswire
News headline image
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
December 08, 2025
Via ACCESS Newswire
News headline image
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
December 04, 2025
Via ACCESS Newswire
News headline image
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
November 12, 2025
Via ACCESS Newswire
News headline image
Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities
November 05, 2025
Via ACCESS Newswire
News headline image
In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties
November 04, 2025
Via ACCESS Newswire
News headline image
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
October 29, 2025
Via ACCESS Newswire
News headline image
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
October 27, 2025
Via ACCESS Newswire
News headline image
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
August 13, 2025
Via ACCESS Newswire
News headline image
Evotec SE to announce first half-year results 2025 on 13 August 2025
August 06, 2025
Via ACCESS Newswire
News headline image
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
Via ACCESS Newswire
News headline image
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
Via ACCESS Newswire
News headline image
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix
July 21, 2025
Via ACCESS Newswire
News headline image
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
July 21, 2025
Via ACCESS Newswire
News headline image
Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury
June 25, 2025
Via ACCESS Newswire
News headline image
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
May 07, 2025
Via ACCESS Newswire
News headline image
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
May 06, 2025
Via ACCESS Newswire
News headline image
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
April 29, 2025
Via ACCESS Newswire
News headline image
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb
April 24, 2025
Via ACCESS Newswire
News headline image
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
April 17, 2025
Via ACCESS Newswire
News headline image
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
April 10, 2025
Via ACCESS Newswire
News headline image
Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases
January 22, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap